Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

In vitro tests for platelet compatibility

L O Cook, W V Miller

    Vox Sanguinis
    |April 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Four platelet compatibility tests were evaluated for predicting post-transfusion platelet increments. None of the investigated methods reliably predicted outcomes in thrombocytopenic patients refractory to platelet therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Paroxysmal cold hemoglobinuria: a case report.

    Immunohematology·2013
    Same author

    High-dose chemotherapy followed by reinfusion of a high number of CD34+ progenitor cells is frequently associated with development of fever in the postengraftment period.

    Journal of hematotherapy & stem cell research·2001
    Same author

    Antibodies to low-incidence antigens and elimination of the antihuman globulin phase of the crossmatch-case report: anti-Wra.

    Immunohematology·1997
    Same author

    "Those were the days".

    Immunohematology·1996
    Same author

    Transfusion of donor buffy coat cells in the treatment of persistent or recurrent malignancy after allogeneic bone marrow transplantation.

    Transfusion·1995
    Same author

    Case report: a pregnant woman with immune thrombocytopenic purpura and unusual red cell antibodies.

    Immunohematology·1995
    Same journal

    Barriers and enablers to non-remunerated plasma donation: A meta-synthesis of the qualitative literature using the theoretical domains framework.

    Vox sanguinis·2026
    Same journal

    Haemolytic disease of the foetus and newborn due to anti-M: A systematic review.

    Vox sanguinis·2026
    Same journal

    In vitro evaluation of apheresis platelet and plasma products collected and stored in non-DEHP disposable sets.

    Vox sanguinis·2026
    Same journal

    Survey of national and regional rare donor programmes regarding Immunoglobulin A deficiency.

    Vox sanguinis·2026
    Same journal

    Fibrinogen recovery in cryoprecipitate prepared from thawed plasma stored for 5 days post-thaw.

    Vox sanguinis·2026
    Same journal

    Abstracts of the 39th International Congress of the ISBT, Kuala Lumpur, Malaysia, 20-24 June 2026.

    Vox sanguinis·2026
    See all related articles

    Area of Science:

    • Hematology
    • Immunology
    • Transfusion Medicine

    Background:

    • Platelet transfusion refractoriness is a significant clinical challenge.
    • Accurate prediction of platelet increment is crucial for effective patient management.

    Purpose of the Study:

    • To assess the reliability of four distinct methods in predicting 24-hour post-transfusion platelet increment.
    • To evaluate the suitability of these methods as platelet compatibility procedures.

    Main Methods:

    • Leukoagglutination assay
    • Lymphocytotoxicity assay
    • Platelet suspension immunofluorescence assay
    • Platelet enzyme-linked immunosorbent assay (ELISA)

    Main Results:

    Related Experiment Videos

    • None of the four investigated methods demonstrated reliable prediction of 24-hour post-transfusion platelet increment.
    • The assays failed to accurately forecast transfusion success in patients refractory to random donor platelets.

    Conclusions:

    • The evaluated platelet compatibility tests are not suitable for reliably predicting outcomes in refractory thrombocytopenic patients.
    • Further research is needed to develop more accurate predictive methods for platelet transfusion compatibility.